Baird analyst David Manthey lowered the firm’s price target on Stericycle to $55 from $62 and keeps a Neutral rating on the shares. The firm said management announced a new subscription-based SID service offering which seems to have potential. Overall, while acknowledging the attractive long-term improvement opportunity, Baird is staying on the sidelines during the early post-ERP deployment period.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRCL: